中草香料(920016) - 2025 Q4 - 年度业绩
ChinaHerbChinaHerb(BJ:920016)2026-02-11 09:55

Financial Performance - The company's operating revenue for 2025 is approximately CNY 234.30 million, representing a year-on-year increase of 5.47% compared to CNY 222.15 million in the previous year[4]. - The total profit for the period is approximately CNY 23.86 million, showing a significant decline of 45.58% from CNY 43.83 million in the previous year[4]. - Net profit attributable to shareholders of the listed company is approximately CNY 20.75 million, down 43.34% from CNY 36.63 million year-on-year[4]. - Basic earnings per share decreased to CNY 0.27, a decline of 52.63% compared to CNY 0.57 in the previous year[4]. Assets and Equity - Total assets at the end of the reporting period are approximately CNY 631.35 million, reflecting a growth of 10.87% from CNY 569.47 million at the beginning of the period[4]. - Shareholders' equity attributable to the listed company is approximately CNY 384.56 million, an increase of 4.82% from CNY 366.88 million[4]. Market Conditions and Challenges - The decline in net profit is primarily attributed to increased competition in the cooling agent market and a significant drop in product prices, leading to reduced gross margins[7]. - Financial costs have increased due to interest expenses from project loans, adding pressure on overall costs[7]. Strategic Focus - The company is focusing on technological innovation and optimizing product structure while advancing the trial production of a project with an annual capacity of 2,600 tons of cooling agents and fragrance raw materials[6]. Cautionary Note - The company warns that the financial data presented is preliminary and has not been audited, urging investors to be cautious[9].

ChinaHerb-中草香料(920016) - 2025 Q4 - 年度业绩 - Reportify